Viral Fusion Proteins

DBCAT002897Pharmacologic class

Proteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells. A DrugBank category of 2 drugs. 1 of them is approved.

Also known as: F Protein (Sendai Virus) · F Protein Measles Virus · F Protein Newcastle Disease Virus · F Protein SV · F-Glycoprotein SV
Drugs: Enfuvirtide
Tifuvirtide

What you can answer from here — as of November 01, 2016

2DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

9Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Viral Fusion Proteins share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account